相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FosB Is Essential for the Enhancement of Stress Tolerance and Antagonizes Locomotor Sensitization by ΔFosB
Yoshinori N. Ohnishi et al.
BIOLOGICAL PSYCHIATRY (2011)
Serotonin 1B Autoreceptors Originating in the Caudal Dorsal Raphe Nucleus Reduce Expression of Fear and Depression-Like Behavior
Ross A. McDevitt et al.
BIOLOGICAL PSYCHIATRY (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance
Susan L. McElroy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
Mark J. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression
Linda Mah et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice
Naoto Omata et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder
Charles B. Schaffer et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania
Zohreh Amrollahi et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Antidepressants for the Acute Treatment of Bipolar Depression: A Systematic Review and Meta-Analysis
Michelle M. Sidor et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Glycogen Synthase Kinase-3β Is a Functional Modulator of Serotonin-1B Receptors
L. Chen et al.
MOLECULAR PHARMACOLOGY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Co-expression of serotonin 5-HT1B and 5-HT4 receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum
Martin Egeland et al.
NEUROPHARMACOLOGY (2011)
Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
Ayseguel Yildiz et al.
NEUROPSYCHOPHARMACOLOGY (2011)
AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice
Jen Q. Pan et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Bipolar Disorder - A Focus on Depression
Mark A. Frye
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats
J. Prins et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Linking Molecules to Mood: New Insight Into the Biology of Depression
Vaishnav Krishnan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Suprachiasmatic Nucleus: Cell Autonomy and Network Properties
David K. Welsh et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
A Role for p11 in the Antidepressant Action of Brain-Derived Neurotrophic Factor
Jennifer L. Warner-Schmidt et al.
BIOLOGICAL PSYCHIATRY (2010)
Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Cagri Yuksel et al.
BIOLOGICAL PSYCHIATRY (2010)
Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
Wayne C. Drevets et al.
BIOLOGICAL PSYCHIATRY (2010)
Regulation of glycogen synthase kinase-3 during bipolar mania treatment
Xiaohong Li et al.
BIPOLAR DISORDERS (2010)
GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and increased reelin proteins in the hippocampus
Joanna M. Wieronska et al.
BRAIN RESEARCH (2010)
5-HT1A receptor-regulated signal transduction pathways in brain
Abigail M. Polter et al.
CELLULAR SIGNALLING (2010)
Agomelatine in the Treatment of Major Depressive Disorder Potential for Clinical Effectiveness
Sidney H. Kennedy et al.
CNS DRUGS (2010)
Therapeutic Options for Treatment-Resistant Depression
Richard C. Shelton et al.
CNS DRUGS (2010)
Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade
Bianca Voss et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2010)
Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006
Manuel Koller et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Sleep deprivation in depression
Ulrich-Michael Hemmeter et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients
Maria-Antonia Quera-Salva et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The Serotonin-7 Receptor as a Novel Therapeutic Target
Stephen M. Stahl
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline
Siegfried Kasper et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial
Stephen M. Stahl et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
Joseph R. Calabrese et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)
Susan L. McElroy et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
John Zajecka et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Rapid Antidepressant Effect of Ketamine Anesthesia During Electroconvulsive Therapy of Treatment-Resistant Depression Comparing Ketamine and Propofol Anesthesia
Nagahisa Okamoto et al.
JOURNAL OF ECT (2010)
Mechanisms Involved in Systemic Nicotine-Induced Glutamatergic Synaptic Plasticity on Dopamine Neurons in the Ventral Tegmental Area
Ming Gao et al.
JOURNAL OF NEUROSCIENCE (2010)
The Anticonvulsive Drug Lamotrigine Blocks Neuronal α4β2 Nicotinic Acetylcholine Receptors
Chao Zheng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Translational research in bipolar disorder: emerging insights from genetically based models
G. Chen et al.
MOLECULAR PSYCHIATRY (2010)
Delta FosB in brain reward circuits mediates resilience to stress and antidepressant responses
Vincent Vialou et al.
NATURE NEUROSCIENCE (2010)
Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression
Becky Inkster et al.
NEUROIMAGE (2010)
Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
Brian P. Brennan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Neurocircuitry of Mood Disorders
Joseph L. Price et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Xiaohua Li et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Differential brain, but not serum VEGF levels in a genetic rat model of depression
Betina Elfving et al.
NEUROSCIENCE LETTERS (2010)
Comparison of hippocampal metabotropic glutamate receptor 7 (mGlu7) mRNA levels in two animal models of depression
Cliona M. O'Mahony et al.
NEUROSCIENCE LETTERS (2010)
Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder
Kyu Young Lee et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Circadian Integration of Metabolism and Energetics
Joseph Bass et al.
SCIENCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens
Brian Alexander et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Yann S. Mineur et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
The novel melatonergic antidepressant, agomelatine, is a neutral antagonist at constitutively-active serotonin2C receptors
M. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Gender differences in antidepressant drug response
Robert Keers et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2010)
Correlates of Treatment-Emergent Mania Associated With Antidepressant Treatment in Bipolar Depression
Mark A. Frye et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics
Neal L. Benowitz
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Personality Change During Depression Treatment A Placebo-Controlled Trial
Tony Z. Tang et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex
Jesper T. Andreasen et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation
Abigail Polter et al.
BIOLOGICAL PSYCHIATRY (2009)
Bcl-2 Polymorphism Influences Gray Matter Volume in the Ventral Striatum in Healthy Humans
Giacomo Salvadore et al.
BIOLOGICAL PSYCHIATRY (2009)
The Serotonin-1A Receptor in Anxiety Disorders
Elena Akimova et al.
BIOLOGICAL PSYCHIATRY (2009)
The anterior cingulate ERK pathway contributes to regulation of behavioral excitement and hedonic activity
Thomas K. Creson et al.
BIPOLAR DISORDERS (2009)
Antipsychotic agents in the treatment of bipolar mania
Mauricio Tohen et al.
BIPOLAR DISORDERS (2009)
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials
John R. Geddes et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Protein Kinase C Inhibitors Rationale for Use and Potential in the Treatment of Bipolar Disorder
Carlos A. Zarate et al.
CNS DRUGS (2009)
Serotonin Receptors, Type 4: A New Hope?
Guillaume Lucas
CURRENT DRUG TARGETS (2009)
The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
B. M. Ruf et al.
CURRENT DRUG TARGETS (2009)
Clinical Uses of Low-Dose Ketamine in Patients Undergoing Surgery
M. Berti et al.
CURRENT DRUG TARGETS (2009)
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect
Hans Rollema et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Electrophysiological characterization of the effects of asenapine at 5-HT1A, 5-HT2A, α2-adrenergic and D2 receptors in the rat brain
Ramez Ghanbari et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia
Gary Richardson et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial
Marc L. M. van der Loos et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study
Michael Bauer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study
Noah S. Philip et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial
Guy M. Goodwin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Role of p11 in Cellular and Behavioral Effects of 5-HT4 Receptor Stimulation
Jennifer L. Warner-Schmidt et al.
JOURNAL OF NEUROSCIENCE (2009)
Cytisine-Based Nicotinic Partial Agonists as Novel Antidepressant Compounds
Yann S. Mineur et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3
Ligong Chen et al.
MOLECULAR PHARMACOLOGY (2009)
The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement
S. R. Engel et al.
MOLECULAR PSYCHIATRY (2009)
5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor
Jonathan Shelton et al.
NEUROPHARMACOLOGY (2009)
Vascular Endothelial Growth Factor Signaling is Required for the Behavioral Actions of Antidepressant Treatment: Pharmacological and Cellular Characterization
Joshua Greene et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: Behavioral and neurochemical studies in rats
Alessandra Tamburella et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
5-HT1A receptor function in major depressive disorder
Jonathan Savitz et al.
PROGRESS IN NEUROBIOLOGY (2009)
Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation
Jean-Michel Aubry et al.
PSYCHOPHARMACOLOGY (2009)
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder
Nancy DiazGranados et al.
Current Psychiatry Reports (2009)
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Oksana Kaidanovich-Beilin et al.
MOLECULAR BRAIN (2009)
Association study of wnt signaling pathway genes in bipolar disorder
Peter P. Zandi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Protein kinase C inhibition in the treatment of mania
Ayseguel Yildiz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out mice
Todd D. Gould et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Antidepressant-like effect of larnotrigine is reversed by veratrine: A possible role of sodium channels in bipolar depression
Corina Prica et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Mood disorders: Regulation by metabotropic glutamate receptors
Andrzej Pilc et al.
BIOCHEMICAL PHARMACOLOGY (2008)
N-acetyl cysteine for depressive symptoms in bipolar disorder - A double-blind randomized placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
Srijan Sen et al.
BIOLOGICAL PSYCHIATRY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Neurotrophin-induced upregulation of p75NTR via a protein kinase C-delta-dependent mechanism
Sherri L. Rankin et al.
BRAIN RESEARCH (2008)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
VEGF as a potential target for therapeutic intervention in depression
Jennifer L. Warner-Schmidt et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus
Chun-Yao Lee et al.
EPILEPSIA (2008)
The Role of AMPA receptor modulation in the treatment of neuropsychiatric diseases
Carlos A. Zarate et al.
EXPERIMENTAL NEUROLOGY (2008)
The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies
Alan J. Gelenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR
Sidney H. Kennedy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder - A preliminary study
Tony P. George et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder - A second multicenter, randomized, double-blind, placebo-controlled study
Ronald N. Marcus et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior
Jing Du et al.
JOURNAL OF NEUROSCIENCE (2008)
Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
J. S. Rao et al.
MOLECULAR PSYCHIATRY (2008)
Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and β-catenin stabilization
Melaine Lamarre et al.
NEUROPHARMACOLOGY (2008)
Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action
Heather A. Mitchell et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3β
Tsuyoshi Hirota et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Jean-Martin Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice
Angelo O. Rosa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Modafinil: A review of neurochemical actions and effects on cognition
Michael J. Minzenberg et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures
Therese A. Kosten et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Stress, depression, and neuroplasticity: A convergence of mechanisms
Christopher Pittenger et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Anxiety as a developmental disorder
E. David Leonardo et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Lithium reduces FoxO3a transcriptional activity by decreasing its intracellular content
Zhengquan Mao et al.
BIOLOGICAL PSYCHIATRY (2007)
Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications
Robert M. Post
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
Major depressive disorder, sleep EEG and agomelatine: an open-label study
Maria-Antonia Quera Salva et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Clozapine and haloperidol differently suppress the MK-801-Increased Glutamatergic and Serotonergic transmission in the medial prefrontal cortex of the rat
Xavier Lopez-Gil et al.
NEUROPSYCHOPHARMACOLOGY (2007)
β-catenin overexpression in the mouse brain phenocopies lithium-sensitive Behaviors
Todd D. Gould et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Association of the HTR2C gene and antipsychotic induced weight gain:: a meta-analysis
Vincenzo De Luca et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Serotonin4 (5-HT4) receptor Agonists are putative antidepressants with a rapid onset of action
Guillaume Lucas et al.
NEURON (2007)
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study
Carlos A. Zarate et al.
BIPOLAR DISORDERS (2007)
New insights into BDNF function in depression and anxiety
Keri Martinowich et al.
NATURE NEUROSCIENCE (2007)
The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
G. Rosenberg
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression
Mark A. Frye et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression
Francesco Benedetti et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex
Myoung-Sun Roh et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
Robert M. Berman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines
Bradley W. Doble et al.
DEVELOPMENTAL CELL (2007)
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents
Pascal Bonaventure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Circadian genes, rhythms and the biology of mood disorders
Colleen A. McClung
PHARMACOLOGY & THERAPEUTICS (2007)
Effectiveness of adjunctive antidepressant treatment for bipolar depression
Gary S. Sachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mania-like behavior induced by disruption of CLOCK
Kole Roybal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders
Jing Du et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice
Yann S. Mineur et al.
NEUROPHARMACOLOGY (2007)
Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms
Gerard Sanacora et al.
BIOLOGICAL PSYCHIATRY (2007)
Regional cerebral glucose metabolic abnormalities in bipolar II depression
Linda Mah et al.
BIOLOGICAL PSYCHIATRY (2007)
p11 (S100A10) - an inducible adaptor protein that modulates neuronal functions
Per Svenningsson et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice
Anna Wesolowska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Lithium regulates glycogen synthase kinase-3β in human peripheral blood mononuclear cells:: Implication in the treatment of bipolar disorder
Xiaohua Li et al.
BIOLOGICAL PSYCHIATRY (2007)
Low cerebrospinal fluid glutamate and glycine in refractory affective disorder
Mark A. Frye et al.
BIOLOGICAL PSYCHIATRY (2007)
Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3β in ventral prefrontal cortex of depressed suicide victims
Felicien Karege et al.
BIOLOGICAL PSYCHIATRY (2007)
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior
Heath D. Schmidt et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Depression during tobacco abstinence
John R. Hughes
NICOTINE & TOBACCO RESEARCH (2007)
The role of dopamine in the pathophysiology of depression
Boadie W. Dunlop et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
MBH Youdim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats
Anna Wesolowska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice
R. L. Rabenstein et al.
PSYCHOPHARMACOLOGY (2006)
Serotonin targets the DAF-16/FOXO signaling pathway to modulate stress responses
Bin Liang et al.
CELL METABOLISM (2006)
Selegiline transdermal system in the prevention of relapse of major depressive disorder - A 52-week, double-blind, placebo-substitution, parallel-group clinical trial
Jay D. Amsterdam et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Neurobiology of the sleep-wake cycle: Sleep architecture, circadian regulation, and regulatory feedback
Patrick M. Fuller et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2006)
Neuronal 5-HT metabotropic receptors:: fine-tuning of their structure, signaling, and roles in synaptic modulation
Joel Bockaert et al.
CELL AND TISSUE RESEARCH (2006)
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial
F. Joseph McClernon et al.
PSYCHOPHARMACOLOGY (2006)
Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice
Xia Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Antidepressant efficacy of the antimuscarinic drug scopolamine - A randomized, placebo-controlled clinical trial
Maura L. Furey et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Selegiline transdermal system for the treatment of major depressive disorder: An 8-week, double-blind, placebo-controlled, flexible-dose titration trial
Alan D. Feiger et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats
Miguel Molina-Hernandez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Transgenic mice overexpressing glycogen synthase kinase 3β:: A putative model of hyperactivity and mania
Jos Prickaerts et al.
JOURNAL OF NEUROSCIENCE (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats
Takao Yoshimizu et al.
PSYCHOPHARMACOLOGY (2006)
Pharmacological profile of the triple monoamine neurotransmitter uptake inhibitor, DOV 102,677
Piotr Popik et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
The fibroblast growth factor system and mood disorders
Cortney A. Turner et al.
BIOLOGICAL PSYCHIATRY (2006)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies
William W. McDaniel et al.
JOURNAL OF ECT (2006)
Preclinical and clinical pharmacology of DOV 216,303, a triple reuptake inhibitor
Phil Skolnick et al.
CNS DRUG REVIEWS (2006)
Psychotropic drugs affect Ser9-phosphorylated GSK-3β protein levels in rodent frontal cortex
Nitsan Kozlovsky et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Modafinil [2-[(diphenylmethyl) sulfinyl]acetamide] and circadian rhythms in Syrian hamsters: Assessment of the chronobiotic potential of a novel alerting compound
IC Webb et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder
J Kulkarni et al.
PSYCHONEUROENDOCRINOLOGY (2006)
A role for AMPA receptors in mood disorders
A Alt et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans
JR Ellis et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Cumulative activation of Akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons
NN Johnson-Farley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Nuclear receptor Rev-erba is a critical lithium-sensitive component of the circadian clock
L Yin et al.
SCIENCE (2006)
Catecholaminergic strategies for the treatment of major depression
P Tremblay et al.
CURRENT DRUG TARGETS (2006)
Alterations in 5-HT1B receptor function by p11 in depression-like states
P Svenningsson et al.
SCIENCE (2006)
A double-blind, placebo-controlled study of memantine in the treatment of major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Pharmacogenomics and antidepressant drugs
EB Binder et al.
ANNALS OF MEDICINE (2006)
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2006)
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
PB Hedlund et al.
BIOLOGICAL PSYCHIATRY (2005)
Valproic acid reduces enhanced vesicular glutamate transporter immunoreactivities in the dentate gyrus of the seizure prone gerbil
TC Kang et al.
NEUROPHARMACOLOGY (2005)
Nicotine addiction and comorbidity with alcohol abuse and mental illness
JA Dani et al.
NATURE NEUROSCIENCE (2005)
A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder
M Fava et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
A role for glycogen synthase kinase-3β in the mammalian circadian clock
C Iitaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking
MM Moran et al.
JOURNAL OF NEUROSCIENCE (2005)
Antidepressant effect of ketamine during ECT
R Ostroff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients
CG Hahn et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
JR Calabrese et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers
D Kalman et al.
NICOTINE & TOBACCO RESEARCH (2005)
The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers
R Zhou et al.
JOURNAL OF NEUROSCIENCE (2005)
Role that phosphorylation of GSK3 plays in insulin
EJ McManus et al.
EMBO JOURNAL (2005)
Circadian rhythm phenotype of 5-HT7 receptor knockout mice:: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing
J Sprouse et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2005)
The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence
RN Golden et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus
G Bonanno et al.
JOURNAL OF NEUROSCIENCE (2005)
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial
RH Weisler et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
M Guscott et al.
NEUROPHARMACOLOGY (2005)
Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
H Alimohamad et al.
BIOLOGICAL PSYCHIATRY (2005)
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
CA Zarate et al.
BIOLOGICAL PSYCHIATRY (2005)
Antiepileptic drugs in mood-disordered patients
P Gajwani et al.
EPILEPSIA (2005)
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression
XD Zhang et al.
NEURON (2005)
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
AJ Kim et al.
JOURNAL OF CELL SCIENCE (2005)
Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil
JP Wisor et al.
NEUROSCIENCE (2005)
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin et al.
BIOLOGICAL PSYCHIATRY (2004)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Assessing the effects of bupropion SR on mood dimensions of depression
AJ Tomarken et al.
JOURNAL OF AFFECTIVE DISORDERS (2004)
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression
JF Goldberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
S Chaki et al.
NEUROPHARMACOLOGY (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Pharmacological inhibitors of glycogen synthase kinase 3
L Meijer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain
XH Li et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
WT O'Brien et al.
JOURNAL OF NEUROSCIENCE (2004)
Modulation of synaptic plasticity by antimanic agents: The role of AMPA glutamate receptor subunit 1 synaptic expression
J Du et al.
JOURNAL OF NEUROSCIENCE (2004)
Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells
WW Zhu et al.
MOLECULAR BRAIN RESEARCH (2004)
Pramipexole for bipolar II depression: A placebo-controlled proof of concept study
CA Zarate et al.
BIOLOGICAL PSYCHIATRY (2004)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
TD Gould et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
5-HT1A receptors, gene repression, and depression: Guilt by association
PR Albert et al.
NEUROSCIENTIST (2004)
The activity of antiepileptic drugs as histone deacetylase inhibitors
S Eyal et al.
EPILEPSIA (2004)
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds
GH Werstuck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
An open-label trial of riluzole in patients with treatment-resistant major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
ME Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus
MJ Duncan et al.
BRAIN RESEARCH (2004)
Serotonin1B receptors:: from protein to physiological function and behavior
Y Sari
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)
I Marenholz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3
Guang Chen et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression
F Benedetti et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder
JR Calabrese et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium - Evidence for autoregulation of GSK-3
F Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram
P Popik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats
DR Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
A fly's eye view of circadian entrainment
LJ Ashmore et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2003)
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder
CL Bowden et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Is there a role for 5-HT1A agonists in the treatment of depression?
P Blier et al.
BIOLOGICAL PSYCHIATRY (2003)
Prophylactic effect of phenytoin in bipolar disorder: a controlled study
A Mishory et al.
BIPOLAR DISORDERS (2003)
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression
M Tohen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
P De Sarno et al.
NEUROPHARMACOLOGY (2002)
Mediators and moderators of treatment effects in randomized clinical trials
HC Kraemer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Lithium and valproic acid: parallels and contrasts in diverse signaling contexts
N Gurvich et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Interaction of lithium with 5-HT1B receptors in depressed unipolar patients treated with clomipramine and lithium versus clomipramine and placebo:: preliminary results
D Januel et al.
PSYCHIATRY RESEARCH (2002)
Coordination of circadian timing in mammals
SM Reppert et al.
NATURE (2002)
BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents
L Mai et al.
JOURNAL OF NEUROCHEMISTRY (2002)
A common mechanism of action for three mood-stabilizing drugs
RSB Williams et al.
NATURE (2002)
The glutamine commute: take the N line and transfer to the A
FA Chaudhry et al.
JOURNAL OF CELL BIOLOGY (2002)
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas
HD Mansvelder et al.
NEURON (2002)
PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers
HK Manji et al.
MOLECULAR PSYCHIATRY (2002)
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling
WH Zheng et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study
YI Sheline et al.
BIOLOGICAL PSYCHIATRY (2001)
Can recovery from depression be achieved.?
RC Shelton et al.
PSYCHIATRIC SERVICES (2001)
GSK3 takes centre stage more than 20 years after its discovery
S Frame et al.
BIOCHEMICAL JOURNAL (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock
S Martinek et al.
CELL (2001)
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
WJ Ryves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β
MT Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
MA Frye et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
XJ Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Multilevel regulation of the circadian clock
N Cermakian et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
Long-term potentiation of excitatory inputs to brain reward areas by nicotine
HD Mansvelder et al.
NEURON (2000)
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
CL Bowden et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Increased cerebrospinal fluid glutamine levels in depressed patients
J Levine et al.
BIOLOGICAL PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania
JM Bebchuk et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex
W Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex - A possible mechanism of neuroprotection in major depression?
AT Michael-Titus et al.
NEUROSCIENCE (2000)
Phenytoin as an antimanic anticonvulsant: A controlled study
A Mishory et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover
BR Henderson
NATURE CELL BIOLOGY (2000)
分享论文
